Medtronic Mediterranean Launches World's First Arabic-Language ...
Posted by ~Ray @ 2007-12-09 14:43:44
Medtronic Mediterranean today announced the Middle East open of the Arabic language Paradigm(R) REAL-Time Insulin handle and Continuous Glucose Monitoring System (Paradigm REAL-Time) a progressive therapy available for patients who use insulin to treat diabetes. It is the first integrated insulin therapy to display real-time continuous glucose readings and trend graphs allowing patients to make immediate self-management decisions to improve their glucose control after confirming readings with a fingerstick measurement. Taking immediate corrective or preventive action can help patients keep healthy glucose levels in request to decelerate or prevent diabetes-related complications including coma blindness kidney failure amputation impotence and heart disease.
The Paradigm REAL-Time System integrates an external insulin pump with continuous glucose monitoring (CGM). The system's glucose sensor takes as many as 288 daily glucose readings per day - providing nearly 100 times more information than three daily fingerstick readings give.
Current standards for assessing glucose hold back consider A1C tests and fingerstick measurements yet both have limitations. An A1C test which measures glucose control over a three-month period is important for long-term management but it is only an add up and does not reveal day-to-day glucose fluctuations that can damage the body. In move fingerstick measurements only show a glucose value at a single moment in time. As a prove patients are unable to detect approximately 60 percent of low glucose (hypoglycemia) events and undergo difficulty assessing glucose fluctuations while they sleep. In contrast real-time CGM allows patients to believe glucose trends throughout the day and night and understand how abstain and in what direction their glucose levels are heading. By discovering how diet apply medication and lifestyle affect their glucose levels patients can make more informed self-management decisions and achieve a greater comprehend of confidence when managing their disease.
The system's continuous glucose sensor is a tiny electrode that is inserted under the climb using the Sen-Serter(R) a small device that makes sensor insertion easy for patients or their caregivers. The sensor measures glucose in the interstitial fluid open between the be's cells and is typically discarded and replaced after three days of use. Glucose measurements obtained by the sensor are relayed every five minutes from a transmitter to the external insulin handle which displays three-hour and 24-hour trend graphs as come up as arrows to indicate how quickly glucose is moving up or drink. In addition an affright alerts patients when glucose levels change state too high or too low.
"In order to manage diabetes properly patients must continually understand what affects their glucose patterns and act challenge to regain control as quickly as possible," states Dr. Khalid Al-Rubeean. Director of University Diabetes Center. King Saud University. Riyadh. Saudi Arabia. "By viewing trends and real-time glucose information patients can program their pump to go away or stop insulin delivery upon demand or they can eat carbohydrates to counteract for low blood sugar. Timely information coupled with precise insulin delivery is why this integrated insulin therapy has the potential to revolutionize diabetes management."
The Paradigm REAL-Time System incorporates "smart" Paradigm 522 or 722 insulin pumps which undergo powerful built-in Bolus Wizard(R) calculators to bring home the bacon the complex diabetes math for patients. These pumps recommend insulin dosages after considering the be of insulin still "active" in the body helping patients forbid dangerous hypoglycemic episodes caused when too much insulin is delivered. The system is calibrated twice a day (every 12 hours) by entering a daub glucose measurement from a standard meter into the insulin pump.
An insulin handle is a small pager-size device that delivers insulin around the measure much like a healthy pancreas. It is the most advanced method for precise and adjustable insulin delivery. Unlike injection therapy pump users can schedule their pump to deliver insulin at varying rates to meet their changing insulin needs throughout the day and night. In addition insulin can be delivered on bespeak at the comprehend of a few buttons. Many patients experience improved quality of life with handle therapy ridding themselves of multiple injections strict meal schedules and rigid sleep patterns that are associated with injection therapy.
Diabetes is reaching epidemic proportions. According to the International Diabetes Federation's latest figures approximately 194 million adults undergo diabetes worldwide and this number is expected to arrive 333 million by the year 2025. In the Middle East more than 20 million people have been diagnosed with diabetes.
Medtronic Diabetes (http://www medtronic-diabetes-me com) is the world leader in insulin pump therapy and continuous glucose monitoring. The affiliate's products include external insulin pumps related disposable products and a continuous glucose monitoring system.
Medtronic. Inc. (http://www medtronic com) headquartered in Minneapolis is the global leader in medical technology alleviating pain restoring health and extending life for millions of populate around the world.
Any forward-looking statements are affect to risks and uncertainties such as those described in Medtronic's Quarterly Report on Form 10-Q for the quarter ended January 27. 2006. Actual results may differ materially from anticipated results.
communicate: Media Enquiries: Rana Hamadeh. Medtronic Mediterranean,Telephone: +961-1-370-670 x297. Email: Rana. Hamadeh@medtronic com. NeilBarrett. GCI Riyadh. telecommunicate: +966-(1)218-0290. Email:Neil. Barrett@gciksa com. Medtronic Customer function Middle East Hotline:+961-347-6311 [ADVERTHERE]Related article:
http://www.devicespace.com/news_story.aspx?StoryID=77306&full=1
0 Comments:
No comments have been posted yet!
|
